BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Seagen Inc.
Genmab
Eli Lilly and Company
Pfizer
Verastem, Inc.
Neonc Technologies, Inc.
Pfizer
AstraZeneca
Revolution Medicines, Inc.
Eli Lilly and Company
Tesaro, Inc.
Eli Lilly and Company
Toray Industries, Inc
AstraZeneca
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Eli Lilly and Company
Actuate Therapeutics Inc.
Taiho Pharmaceutical Co., Ltd.
Cantargia AB
Emory University
Canadian Cancer Trials Group
Nektar Therapeutics
Incyte Corporation
Gilead Sciences